Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Relative Risk01:12

Relative Risk

117
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
117
Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

158
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
158
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reference Range of Red Cell Distribution Width-to-Albumin Ratio in Healthy US Adults: A Cross-Sectional Study.

BioMed research international·2026
Same author

Association Between Red Blood Cell Distribution Width-To-Albumin Ratio and Breast, Colorectal, Lung, and Prostate Cancers.

Cancer medicine·2026
Same author

Advancing ICOS agonism in solid tumors: lessons from INDUCE-1.

Journal for immunotherapy of cancer·2026
Same author

Uncertain use of a fixed p value significance threshold in randomized clinical trials.

Trials·2026
Same author

The <i>P</i> Value: What It Is and What It Is Not.

Journal of Korean medical science·2025
Same author

On the effect of flexible adjustment of the p value significance threshold on the reproducibility of randomized clinical trials.

PloS one·2025
Same journal

EGFR and Its Ligands in Idiopathic Pulmonary Fibrosis: Predicting Clinical Outcomes and Molecular Endotyping Through In-Depth Analysis.

Journal of Korean medical science·2026
Same journal

<i>APOE</i> Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.

Journal of Korean medical science·2026
Same journal

Two-Year Outcomes of a Randomized Controlled Trial of Nonintervention Versus Oral Ibuprofen for Patent Ductus Arteriosus in Premature Infants.

Journal of Korean medical science·2026
Same journal

Technology-Dependent Children Living at Home in Korea: A Population-Based Analysis Using NHIS Claims Data.

Journal of Korean medical science·2026
Same journal

Retracted Publications Related to Statistics: A Scopus-Based Bibliometric Analysis.

Journal of Korean medical science·2026
Same journal

Tuberculosis Development in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study.

Journal of Korean medical science·2026
查看所有相关文章

相关实验视频

Updated: Jun 7, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

医学研究中的风险调整:一只鸟的视角

Parham Habibzadeh1, Farrokh Habibzadeh2

  • 1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Journal of Korean medical science
|November 19, 2024
PubMed
概括
此摘要是机器生成的。

观察性研究需要风险调整方法来纠正群体之间的先前存在的差异. 这确保了在临床医学中准确的治疗效果估计,当随机试验不可行时.

关键词:
提供医疗保健服务.观察性研究 观察性研究风险调整 风险调整统计模型 统计模型

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

相关实验视频

Last Updated: Jun 7, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

科学领域:

  • 临床医学 临床医学
  • 流行病学 流行病学
  • 生物统计学 生物统计学

背景情况:

  • 随机临床试验是治疗疗效评估的黄金标准.
  • 当随机试验不可行时,需要进行观察性研究.
  • 在观察性研究中缺乏随机化可能会导致因先前存在的变量差异而导致偏见的治疗效果估计.

研究的目的:

  • 解释风险调整方法在观察性研究中的重要性.
  • 概述应用风险调整用于不偏见的治疗效应估计所涉及的步骤.

主要方法:

  • 定义感兴趣的结果并确定潜在的预测因素.
  • 操作化选择的风险因素.
  • 构建统计模型或使用其他调整方法.

主要成果:

  • 风险调整可以解释年龄,种族和医疗保健质量等变量的先验差异.
  • 统计建模和其他调整技术可以减轻治疗效应估计的偏差.

结论:

  • 风险调整对于在观察性研究中获得准确而公正的治疗效果测量至关重要.
  • 正确应用风险调整可以提高基于观察数据的临床决策的可靠性.